Granulocyte-monocyte Apheresis in Ulcerative Colitis
Not Applicable
Completed
- Conditions
- Ulcerative Colitis
- Registration Number
- NCT03189888
- Lead Sponsor
- Valduce Hospital
- Brief Summary
BACKGROUND: Granulocyte-monocyte apheresis has been proposed for the treatment of ulcerative colitis, although is limited by costs and variability of results.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 33
Inclusion Criteria
- moderate UC with steroid-dependence and azathioprine intolerance or resistance
Exclusion Criteria
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method steroid-free clinical remission 3 months
- Secondary Outcome Measures
Name Time Method